Turning Point Therapeutics, Inc. Operating Expenses
Turning Point Therapeutics, Inc. reported Operating Expenses of $124.48 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2022-08-08
- Turning Point Therapeutics, Inc. operating expenses for the quarter ending 2022-06-30 was $124.48M, a 101.36% increase year-over-year.
- Turning Point Therapeutics, Inc. operating expenses for the quarter ending 2022-03-31 was $75.36M, a 23.04% increase year-over-year.
- Turning Point Therapeutics, Inc. operating expenses for the quarter ending 2021-12-31 was $78.64M, a 64.04% increase year-over-year.
- Turning Point Therapeutics, Inc. operating expenses for the quarter ending 2021-09-30 was $67.11M, a 54.14% increase year-over-year.
- Turning Point Therapeutics, Inc. operating expenses for fiscal 2021 was $268.83M, a 43.89% increase from fiscal 2020.
- Turning Point Therapeutics, Inc. operating expenses for fiscal 2020 was $186.84M, a 140.38% increase from fiscal 2019.
- Turning Point Therapeutics, Inc. operating expenses for fiscal 2019 was $77.72M, a 203.14% increase from fiscal 2018.
- Turning Point Therapeutics, Inc. operating expenses for fiscal 2018 was $25.64M, a 53.27% increase from fiscal 2017.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2022-06-30 | $124.48M 10-Q · filed 2022-08-08 | $199.85M 10-Q · filed 2022-08-08 | $278.49M derived: sum of 3 quarters · filed 2022-08-08 | $345.60M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2022-03-31 | $75.36M 10-Q · filed 2022-05-10 | $154.00M derived: sum of 2 quarters · filed 2022-05-10 | $221.12M derived: sum of 3 quarters · filed 2022-05-10 | $282.94M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-12-31 | $78.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $145.75M derived: sum of 2 quarters · filed 2022-02-28 | $207.57M derived: sum of 3 quarters · filed 2022-08-08 | $268.83M 10-K · filed 2022-02-28 | |
| 2021-09-30 | $67.11M 10-Q · filed 2021-11-09 | $128.93M derived: sum of 2 quarters · filed 2022-08-08 | $190.19M 10-Q · filed 2021-11-09 | $238.13M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-06-30 | $61.82M 10-Q · filed 2022-08-08 | $123.08M 10-Q · filed 2022-08-08 | $171.01M derived: sum of 3 quarters · filed 2022-08-08 | $214.55M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-03-31 | $61.25M 10-Q · filed 2022-05-10 | $109.19M derived: sum of 2 quarters · filed 2022-05-10 | $152.73M derived: sum of 3 quarters · filed 2022-05-10 | $185.46M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | $47.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $91.48M derived: sum of 2 quarters · filed 2022-02-28 | $124.21M derived: sum of 3 quarters · filed 2022-02-28 | $186.84M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $43.54M 10-Q · filed 2021-11-09 | $76.27M derived: sum of 2 quarters · filed 2021-11-09 | $138.90M 10-Q · filed 2021-11-09 | $161.96M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $32.73M 10-Q · filed 2021-08-09 | $95.36M 10-Q · filed 2021-08-09 | $118.42M derived: sum of 3 quarters · filed 2022-02-28 | $140.56M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | $62.63M 10-Q · filed 2021-05-05 | $85.69M derived: sum of 2 quarters · filed 2022-02-28 | $107.83M derived: sum of 3 quarters · filed 2022-02-28 | $126.28M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $23.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $45.20M derived: sum of 2 quarters · filed 2022-02-28 | $63.66M derived: sum of 3 quarters · filed 2022-02-28 | $77.72M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $22.14M 10-Q · filed 2020-11-12 | $40.59M derived: sum of 2 quarters · filed 2020-11-12 | $54.66M 10-Q · filed 2020-11-12 | $64.14M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $18.45M 10-Q · filed 2020-08-10 | $32.52M 10-Q · filed 2020-08-10 | $42.00M derived: sum of 3 quarters · filed 2021-03-01 | $48.13M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $14.06M 10-Q · filed 2020-05-12 | $14.06M 10-Q · filed 2019-05-31 | $23.55M derived: sum of 2 quarters · filed 2021-03-01 | $29.67M derived: sum of 3 quarters · filed 2021-03-01 | $34.85M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $9.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $15.61M derived: sum of 2 quarters · filed 2021-03-01 | $20.78M derived: sum of 3 quarters · filed 2021-03-01 | $25.64M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $6.13M 10-Q · filed 2019-11-04 | $11.30M derived: sum of 2 quarters · filed 2019-11-04 | $16.16M 10-Q · filed 2019-11-04 | ||
| 2018-06-30 | $5.17M 10-Q · filed 2019-08-06 | $10.03M 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | $4.86M 10-Q · filed 2019-05-31 | ||||
| 2017-12-31 | $16.73M 10-K · filed 2020-03-18 |